Have a feature idea you'd love to see implemented?
Let us know!
NUTX Nutex Health Inc
Price (delayed)
$31.89
Market cap
$173.39M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$9.39
Enterprise value
$429.72M
nutex health is a consortium of licensed 24/7 free standing emergency centers. our philosophy is simple: bring concierge level, high quality emergency care to the local community. we build the
Highlights
The company's gross margin has surged by 194% YoY and by 21% QoQ
The company's quick ratio rose by 39% YoY and by 14% QoQ
The debt has contracted by 7% YoY but it has grown by 5% from the previous quarter
NUTX's EPS has shrunk by 50% YoY and by 5% QoQ
The net income is down by 42% year-on-year and by 9% since the previous quarter
Key stats
What are the main financial stats of NUTX
Market
Valuations
Earnings
Shares outstanding
5.44M
Market cap
$173.39M
Enterprise value
$429.72M
Price to earnings (P/E)
N/A
Price to book (P/B)
2.67
Price to sales (P/S)
0.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.47
Revenue
$292M
EBIT
-$19.15M
EBITDA
-$731,873
Free cash flow
$20.24M
Per share
Balance sheet
Liquidity
EPS
-$9.39
Free cash flow per share
$4
Book value per share
$11.93
Revenue per share
$57.64
TBVPS
$80.68
Total assets
$438.49M
Total liabilities
$358.71M
Debt
$303.24M
Equity
$60.44M
Working capital
$52.24M
Debt to equity
5.02
Current ratio
1.77
Quick ratio
1.68
Net debt/EBITDA
-350.24
Margins
Efficiency
Dividend
EBITDA margin
-0.3%
Gross margin
23.2%
Net margin
-14.1%
Operating margin
-3.3%
Return on assets
-9.9%
Return on equity
-66.4%
Return on invested capital
-3.4%
Return on capital employed
-5.2%
Return on sales
-6.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NUTX stock price
How has the Nutex Health stock price performed over time
Intraday
5.14%
1 week
1.79%
1 month
42.88%
1 year
-11.07%
YTD
18.11%
QTD
46.96%
Financial performance
How have Nutex Health's revenue and profit performed over time
Revenue
$292M
Gross profit
$67.85M
Operating income
-$9.73M
Net income
-$41.13M
Gross margin
23.2%
Net margin
-14.1%
The company's gross margin has surged by 194% YoY and by 21% QoQ
Nutex Health's operating margin has surged by 55% QoQ and by 33% YoY
NUTX's operating income has surged by 52% since the previous quarter and by 15% year-on-year
The net income is down by 42% year-on-year and by 9% since the previous quarter
Growth
What is Nutex Health's growth rate over time
Valuation
What is Nutex Health stock price valuation
P/E
N/A
P/B
2.67
P/S
0.55
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.47
NUTX's EPS has shrunk by 50% YoY and by 5% QoQ
The P/B is 105% above the last 4 quarters average of 1.3 but 21% below the 5-year quarterly average of 3.4
NUTX's equity is down by 33% YoY and by 3.7% from the previous quarter
The stock's price to sales (P/S) is 83% more than its last 4 quarters average of 0.3 but 77% less than its 5-year quarterly average of 2.4
The revenue is up by 26% year-on-year and by 6% since the previous quarter
Efficiency
How efficient is Nutex Health business performance
Nutex Health's return on equity has shrunk by 113% YoY and by 21% QoQ
NUTX's ROA has plunged by 52% YoY and by 11% from the previous quarter
Nutex Health's ROIC has decreased by 48% YoY but it has increased by 11% from the previous quarter
NUTX's ROS is up by 18% QoQ but it is down by 8% YoY
Dividends
What is NUTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NUTX.
Financial health
How did Nutex Health financials performed over time
The total assets is 22% greater than the total liabilities
The company's quick ratio rose by 39% YoY and by 14% QoQ
The current ratio has grown by 32% YoY and by 11% from the previous quarter
The debt to equity has grown by 38% YoY and by 9% from the previous quarter
NUTX's equity is down by 33% YoY and by 3.7% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.